Interplay Bio
MI - YpsilantiBiotechnology
Focus: Interplay Bio is a Michigan-based biotechnology company leveraging its proprietary LigandPro Platform to develop targeted protein degradation therapeutics in oncology. The company operates a portfolio structure with both core Interplay programs and portfolio company investments.
Profile data last refreshed 6h ago · AI intelligence enriched 1w ago
Open Jobs
12
Should You Work at Interplay Bio?
AI assessmentInterplay Bio is a high-risk, high-learning opportunity for early-career scientists and platform builders willing to operate without clinical validation or established revenue.
Why Work Here
- Access to cutting-edge LigandPro Platform technology, a differentiated approach to targeted protein degradation in a high-value oncology space
- Lean organizational structure (11 active roles) suggests meaningful individual impact and cross-functional exposure in a focused biotech environment
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Interplay Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.